Filter Results


Study status

(for at least one location)



Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 11 for Heart attack

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

    Scottsdale/Phoenix, AZ

  2. Home Telemonitoring In Patients after Myocardial Infarction

    Rochester, MN

  3. A Study to Evaluate the Safety of Intracoronary Infusion of Extracellular Vesicles in Patients with Acute Myocardial Infarction

    Rochester, MN

  4. Myocardial Ischemia and Transfusion

    Rochester, MN

  5. A Study of Biomarkers for Human Heart Failure

    Rochester, MN

  6. A Study to Identify Late-Occurring Complications in Childhood Cancer Survivors

    Rochester, MN

  7. A Study to Evaluate Cardiac Magnetic Resonance Elastrography (MRE) of Acute Myocardial Infarcts

    Rochester, MN

  8. Serological Strategy to Optimize Prognostic Stratification in Myocardial Infarction

    Rochester, MN

  9. A Study to Measure Physical Activity and Sedentary Behavior During Cardiac Rehabilitation

    Rochester, MN

  10. A Study of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction

    Jacksonville, FL


Mayo Clinic Footer